ChemSpider 2D Image | Galantamine hydrobromide (JAN/USAN) | C17H22BrNO3

Galantamine hydrobromide (JAN/USAN)

  • Molecular FormulaC17H22BrNO3
  • Average mass368.266 Da
  • Monoisotopic mass367.078308 Da
  • ChemSpider ID108491
  • defined stereocentres - 3 of 3 defined stereocentres


More details:






Validated by Experts, Validated by Users, Non-Validated, Removed by Users

(4aS,6R,8aS)-3-méthoxy-11-méthyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazépin-6-ol bromhydrate
(4aS,6R,8aS)-3-methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-ol hydrobromide
(4aS,6R,8aS)-3-Methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-6-olhydrobromid
193146-85-9 [RN]
1953-04-4 [RN]
217-780-5 [EINECS]
5N4SA4KQX9
6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,6R,8aS)-, hydrobromide
6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,6R,8aS)-, hydrobromide (1:1) [ACD/Index Name]
DF8075000
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

MJ4PTD2VVW [DBID]
04.04.1953 [DBID]
D02173 [DBID]
G1660_SIGMA [DBID]
GP-37267 [DBID]
LS-185021 [DBID]
Prestwick_236 [DBID]
R-113675 [DBID]
UN 2811 [DBID]
UN2811 [DBID]
More...
  • Experimental Physico-chemical Properties
  • Predicted Physico-chemical Properties
  • Miscellaneous
    • Bio Activity:

      AChE MedChem Express HY-A0009
      Cholinesterase inhibitor Tocris Bioscience 0686, 686
      Cholinesterases Tocris Bioscience 686
      Enzymes Tocris Bioscience 686
      Esterases Tocris Bioscience 686
      Galanthamine hydrobromide is a long-acting, centrally active acetylcholinesterase(AChE) inhibitor (IC50 = 410 nM) and allosteric potentiator at neuronal nicotinic ACh receptors. MedChem Express http://www.medchemexpress.com/Bosentan-hydrate.html, HY-A0009
      Long-acting, centrally active acetylcholinesterase inhibitor (IC50 = 410 nM) and allosteric potentiator at neuronal nicotinic ACh receptors. Prevents ?-amyloid-induced apoptosis in SH-SY5Y and bovine chromaffin cells. Long-term administration reduces amyloid precursor protein deposition and neurodegeneration in a mouse model of Alzheimer's disease. Tocris Bioscience 0686
      Long-acting, centrally active acetylcholinesterase inhibitor (IC50 = 410 nM) and allosteric potentiator at neuronal nicotinic ACh receptors. Prevents ?-amyloid-induced apoptosis in SH-SY5Y and bovine chromaffin cells. Long-term administration reduces amyloid precursor protein deposition and neurodegeneration in a mouse model of Alzheimer's disease. Tocris Bioscience 686
      Long-acting, centrally active acetylcholinesterase inhibitor (IC50 = 410 nM) and allosteric potentiator at neuronal nicotinic ACh receptors. Prevents beta-amyloid-induced apoptosis in SH-SY5Y and bovine chromaffin cells. Long-term administration reduces amyloid precursor protein deposition and neurodegeneration in a mouse model of Alzheimer's disease. Tocris Bioscience 686
      Neuronal Signaling MedChem Express HY-A0009
      Neuronal Signaling; MedChem Express HY-A0009

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

No predicted properties have been calculated for this compound.

Click to predict properties on the Chemicalize site






Advertisement